Can Wealth Of Molecular Data Enable Promise Of Chemoprevention?
This article was originally published in Pharmaceutical Approvals Monthly
The same advances in scientific understanding of the molecular basis of cancer that have propelled the rise of targeted oncologics also hold out the tantalizing prospect of expanded chemoprevention in cancer, the American Association for Cancer Research suggests in its Cancer Progress Report 2011.
You may also be interested in...
Cancer metabolism specialist Agios extends research collaboration with Celgene, picking up an additional $20 million.
Each week, “The Pink Sheet” presents commentary on some of the week’s most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at http://invivoblog.blogspot.com.